Lv3
212 积分 2025-09-23 加入
Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period
16小时前
待确认
Self-management of diabetes in hospital: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group
1天前
已完结
Euglycemic diabetic ketoacidosis
6天前
已完结
Renal conservation of ketone bodies during starvation
6天前
已完结
Renal Handling of Ketones in Response to Sodium–Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
6天前
已完结
Two Cases of Thyrotoxicosis and Euglycemic Diabetic Ketoacidosis Under Sodium-glucose Transport Protein 2 Inhibitor Treatment
10天前
已完结
Euglycemic diabetic ketoacidosis: Rising incidence, diagnostic delays, and the impact of SGLT2 inhibitors in hospitalized patients
12天前
已完结
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
13天前
已完结
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data
13天前
已完结
SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment
13天前
已完结
皖公网安备34019202002308
